Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2022 October;63(5) > The Journal of Cardiovascular Surgery 2022 October;63(5):581-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

REVIEW  ENDOVASCULAR TREATMENT OF LONG FEMOROPOPLITEAL DISEASE 

The Journal of Cardiovascular Surgery 2022 October;63(5):581-6

DOI: 10.23736/S0021-9509.22.12374-8

Copyright © 2022 EDIZIONI MINERVA MEDICA

lingua: Inglese

Bare metal stent in the area of drug eluting devices for long femoropopliteal lesions

Bahaa NASR 1, 2 , Maxime DUBOSQ 3, Yann GOUËFFIC 4

1 Department of Vascular and Endovascular Surgery, Brest University Hospital, Brest, France; 2 INSERM UMR 1101, LaTIM, Brest, France; 3 Aortic Center, Institut Cœur-Poumon, CHU Lille, Lille, France; 4 Department of Vascular and Endovascular Surgery, Paris St. Joseph Hospital, Paris, France



The advancement in the endovascular treatment and the introduction of novel techniques allowed treatment of more complex and longer femoropopliteal lesions. However, the optimal treatment modality is still a source of controversy. The use of bare metal stents (BMS) showed good results for long femoropopliteal lesions. In this review, we summarized all available data on the different treatment strategies of long femoro-popliteal lesions using BMS. Nevertheless, RCTs with head-to-head comparison between BMS strategies are still needed to have more clarification on the best strategy for the endovascular treatment of long femoropopliteal occlusive lesions.


KEY WORDS: Peripheral arterial occlusive disease; Self expandable metallic stents; Endovascular procedures

inizio pagina